Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Different Clinical Courses for Poisoning with WHO Hazard Class Ia Organophosphates EPN, Phosphamidon, and Terbufos in Humans

Mun JG, Moon JM, Lee MJ, Chun BJ

PURPOSE: Extremely hazardous pesticides are classified as World Health Organization (WHO) hazard class Ia. However, data describing the clinical course of WHO class Ia OP (organophosphate) poisonings in humans are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intermediate Myasthenia Syndrome Following Organophosphate Intoxication

Ko JW, Park JS, Lee KR, Chung SP, Lee HS

  • KMID: 2100585
  • J Korean Soc Emerg Med.
  • 2000 Dec;11(4):579-585.
BACKGROUND: Intermediate myasthenia syndrome(IMS) is thought to have clinical importance because it may cause sudden respiratory failure during the recovery phase of a cholinergic crisis of organophosphate poisoning. We designed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Variations in Clinical Features According to Intoxicants in High Toxicity Organophosphorus Intoxication

Kim MJ, Lee BK, Jeung KW, Ryu HH, Moon JM

  • KMID: 2332660
  • J Korean Soc Emerg Med.
  • 2009 Aug;20(4):392-398.
PURPOSE: Organophosphorus (OP) pesticides are differentiated into 3 groups according to their toxicity. The differences in chemical composition of each OP pesticide determines its toxicokinetic characteristics. There are few human...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics of Acute Dichlorvos Poisoning in Korea

Lee MJ, Park JS, Kwon WY, Eo EK, Oh BJ, Lee SW, Suh JH, Roh HK

  • KMID: 2203493
  • J Korean Soc Clin Toxicol.
  • 2008 Jun;6(1):9-15.
Purpose: Dichlorvos has been in widespread use as an organophosphate (OP) insecticide compound. The purpose of this study was to access the epidemiology and clinical features of dichlorvos in Korea. Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr